Skip to main content

MoneyWorks4Me

Neuland Laboratories informs about disclosure

02 Mar 2021 Evaluate

Neuland Laboratories has informed that the exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Steadview Capital Mauritius & PACs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..